Indications
Krx Aesthetics PD-13 Therapy, which includes 13% of Methyl Aminolevulinate HCI, is developed to maximize the client’s satisfaction for PDT(Photo Dynamic Therapy).
Warnings and precautions
1. Keep out of reach of children 2. If irritation occurs, consult your dermatologist and stop usage. Please, check how to use the product and the precautions before you use it.
Official product information
This product has no Drugs@FDA application number in our table. DailyMed holds the labels the manufacturers submit.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- KRX Aesthetics PD-13 Therapy
- Application
- LABEL-KRX Aesthetics PD-13 Therapy
- NDC
- 84755-0010-1